Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,700 | 127,700 | 117,000 | 106,500 | 104,300 |
| Receivables | 142,700 | 167,900 | 146,200 | 145,400 | 161,600 |
| Inventories | 200,000 | 132,300 | 193,600 | 169,000 | 157,600 |
| Other current assets | 0 | 182,300 | 0 | 0 | 0 |
| TOTAL | $453,800 | $624,100 | $470,000 | $437,100 | $439,200 |
| Non-Current Assets | |||||
| PPE Net | 163,500 | 118,600 | 163,400 | 164,300 | 166,900 |
| Intangibles | 1,066,200 | 994,500 | 1,082,300 | 1,089,900 | 1,097,100 |
| Other Non-Current Assets | 51,400 | 49,700 | 59,500 | 61,500 | 63,300 |
| TOTAL | $1,281,100 | $1,162,800 | $1,305,200 | $1,315,700 | $1,327,300 |
| Total Assets | $1,734,900 | $1,786,900 | $1,775,200 | $1,752,800 | $1,766,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,200 | 6,200 | 6,200 | 4,700 | N/A |
| Accounts payable and accrued liabilities | 59,600 | 67,900 | 62,700 | 64,200 | 63,800 |
| Accrued Expenses | 80,600 | 97,800 | 80,000 | 68,700 | 74,600 |
| Other current liabilities | N/A | 7,100 | N/A | N/A | N/A |
| TOTAL | $158,500 | $191,000 | $162,300 | $151,100 | $152,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 204,700 | 226,300 | 247,800 | 249,300 | 254,400 |
| Other Non-Current Liabilities | 47,900 | 53,000 | 64,600 | 66,100 | 68,000 |
| TOTAL | $277,700 | $304,700 | $349,400 | $350,100 | $357,100 |
| Total Liabilities | $436,200 | $495,700 | $511,700 | $501,200 | $510,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,667 | 46,599 | 46,498 | 46,487 | 47,325 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -253,600 | -253,100 | -270,000 | -293,100 | -304,500 |
| Other shareholders' equity | -31,200 | -35,600 | -43,300 | -38,200 | -31,800 |
| TOTAL | $1,298,700 | $1,291,200 | $1,263,500 | $1,251,600 | $1,256,500 |
| Total Liabilities And Equity | $1,734,900 | $1,786,900 | $1,775,200 | $1,752,800 | $1,766,500 |